• Home
  • Victims
    • Vaccine Victims Memorial
    • Gardasil & Silgard
      • G / S Australasia
        • G / S Australia
        • G / S New Zealand
      • G / S Europe
        • G / S Czech Republic
        • G / S Denmark
        • G / S France
        • G / S Germany
        • G / S Ireland
        • G / S Italy
        • G / S Norway
        • G / S Scotland
        • G / S Spain
        • G / S United Kingdom
      • G / S N. America
        • G / S Canada
        • G / S Mexico
        • G / S United States
      • G / S S. America
        • G / S Brazil
        • G/S Colombia
    • Cervarix
      • Cervarix Asia
        • Cervarix India
        • Cervarix Philippines
      • Cervarix Europe
        • Cervarix Czech
        • Cervarix Netherlands
        • Cervarix Scotland
        • Cervarix Slovakia
        • Cervarix Spain
        • Cervarix UK
      • Cervarix N. America
        • Cervarix Mexico
  • Resources
    • HPV Testing Resources
      • Pre-HPV Vaccination
      • Post-HPV Vaccination
    • Medical Professionals
    • Vaccine Injury Attorneys
    • Political Action Groups
    • Vaccine Groups
    • Vaccine Victims Hotline
  • SANE Vax Press Releases
  • Videos
    • Vaccine Safety Videos
    • Vaccine Victim Videos
    • Pharma Videos
  • About
    • About Us
    • Who We Are
    • Press Releases
    • SANE Vax in the News
    • Contact Us

SaneVax, Inc.

The First International HPV Vaccine Information Clearinghouse

  • NEWS
    • Government Agencies
      • African
      • Asian
      • Australasian
      • European
      • North American
      • South American
      • United Nations
      • WHO
    • Pharmaceutical Companies
      • CSL Biotherapies
      • GlaxoSmithKline
      • Inovio Pharmaceuticals
      • Liquidia Technologies
      • Merck & Co.
      • Novartis
      • Pfizer
      • Qiagen
      • Sanofi Aventis
      • Sanofi Pasteur MSD spmsd
      • Wyeth Laboratories
    • Science & Medicine
      • Cancer
      • Clinical Trials
      • Environmental Health
      • Heavy Metal Toxicity
      • HPV Science
      • Influenza
      • Meningitis
      • Pertussis
      • Pharmaceuticals
      • Rotavirus
      • STD’s
      • Vaccine Science
      • Women’s Health
    • Vaccine Adverse Events
    • Vaccine Injury Reporting
      • VAERS
      • VAMPSS
    • Vaccine Litigation
    • Vaccine Marketing
    • Vaccine Politics/People
    • Vaccine Victims
      • Cervarix Injuries
      • DTP/DTaP Injuries
      • Fluvax Injuries
      • Fluzone Injuries
      • Gardasil / Silgard Injuries
      • Menomune Injuries
      • MMR Injuries
      • Polio Vaccine Injuries
      • Synflorix Injuries
      • Yellow Fever Vaccine
    • Vaccines
      • Anthrax
      • Breast Cancer
      • Chicken Pox
      • Cholera
      • Combination Vaccines
      • Diphtheria
      • Hepatitis B
      • HPV
      • Influenza Vaccines
      • Malaria
      • Measles
      • Meningitis Vaccines
      • MRSA
      • Mumps
      • Norovirus
      • Pertussis Vaccines
      • Pneumococcal Disease
      • Polio
      • Rotavirus Vaccines
      • Shingles
      • Smallpox
      • TB
      • Tetanus
      • Typhoid
      • Yellow Fever Vaccine
    • Vaccines and the Media
  • WORLD NEWS
    • Africa
    • Asia
    • Australasia
    • Europe
    • North America
    • South America
  • RESEARCH
    • Cancer Research
    • Cervarix Vaccine
    • Gardasil/Silgard Vaccine
    • Human Pap. Research
    • Immunization Practices
    • Neurology
    • Vaccine Adjuvants
    • Vac. Ingredient Research
    • Vaccine Injuries
    • Vaccine Preservatives
    • Vaccine Related Research
    • Vaccine Safety
  • CITIZENS SPEAK
    • Cervical Cancer Debate
    • HPV Vax
      • Australian Concerns
      • Canadian Concerns
      • Irish Concerns
      • Spain Concerns
      • UK Concerns
      • United States Concerns
You are here: Home / Citizens Speak / HPV Vax / United States Concerns / SANE Vax to CDC: Request for post-HPV vaccination monitoring data

SANE Vax to CDC: Request for post-HPV vaccination monitoring data

August 31, 2011 By Norma 1 Comment

Lauri Markowitz, M.D. 
Centers for Disease Control and Prevention
MS E05, 1600 Clifton Road
Atlanta, GA 30333
lem2@cdc.gov

July 26, 2011

Dear Dr. Markowitz:

Thank you for your letter dated July 14, 2011 in response to the SaneVax Inc. letter of  28 May 2011, concerning the post-licensure monitoring project on Gardasil™, which was approved for marketing under the Fast Track Drug Development Programs in 2006.

Your letter stated, “Beginning in 2003, cervicovaginal swabs have been collected from women participating in the National Health and Nutrition Evaluation Survey (NHANES).  These swabs are tested to determine individual HPV types. Types will continue to be monitored to evaluate changes after vaccine introduction.”

We are now eight (8) years past the inception of said program and five (5) years since Gardasil™ was first approved for marketing in the United States. Therefore, on behalf of concerned medical consumers, S.A.N.E. Vax, Inc. respectfully requests a copy of the monitoring data over the past 8 years. We would like to know specifically if mass vaccination of young women has indeed reduced the prevalence of the vaccine-relevant HPV genotypes as compared to other HPV genotypes in theU.S. population.

Your letter also stated, “CDC is participating in two ongoing special projects to evaluate HPV types in women who have cervical precancer lesions.   Sites in five states (California,Connecticut,New York,OregonandTennessee) have developed a population-based system for monitoring cervical intraepithelial neoplasia (CIN) grade 2 or 3 and adenocarcinoma in situ and associated HPV types.  In addition to collecting standard basic surveillance data on all reported cases, this project is determining HPV types in the precancers.”

In order to be able to assure medical consumers that these “ongoing special projects” are effectively implemented, we would like to ask you to fill in the numbers of HPV genotypes as supplied by these five states in the past 5 years in the Table attached so that we can post the results on our website to inform the public. The purpose of the Table is to present the number ofCIN2/3 and AIS associated with HPV type in each case from 2006 to 2011 to determine if the prevalence of the vaccine-relevant HPV genotypes is indeed decreasing in the precancer lesions among the vaccinated population, as compared to the non-vaccinated population.

In this era of government budget crisis, we would like to know the cost for the CDC’s ongoing special projects to evaluate HPV types in women who have cervical precancerous lesions in those five states mentioned above. Taxpaying medical consumers need some assurance that their money is being wisely spent. If these projects have not generated any meaningful data in the past five years, perhaps they should be abolished and replaced by some other more cost-effective means of post-licensure monitoring.

The SaneVax Team finds your statement “Since HPV genotyping is not done in clinical practice, it is not feasible to have HPV genotypes from all patients with Pap test results indicating cervical precancer or cancer reported to CDC” to be quite disturbing for two reasons. First, the CDC should have known that HPV genotyping has been done in clinical practice for years in the U.S., and there are two FDA-approved commercial test kits for HPV genotyping on the market now.  Second, if the CDC believes HPV genotyping is not done in clinical practice, then the CDC should have known that “determining HPV types in the precancers” for post-licensure monitoring in clinical practice is not possible. However, the CDC felt quite comfortable to endorsing the vaccine Gardasil™, whose approval requires post-licensure monitoring based on using HPV genotyping, for use in clinical practice. The CDC should recommend that since HPV genotyping is not done in clinical practice, Gardasil™ should not be endorsed for use in clinical practice.

We are looking forward to your further comments on behalf of the CDC.

Sincerely,
Norma Erickson, President
SaneVax Inc. 

cc.

Director of CDC- Thomas R. Frieden – txf2@cdc.gov
FDA commissioner – Margaret Hamburg – Margaret.Hamburg@fda.hhs.gov
Secretary of HHS – Kathleen Sebelius – Kathleen.Sebelius@hhs.gov 
 

View the CDC’s response here.   

View the data provided by the CDC, complete with independent analysis here.

 

 

Related

Filed Under: United States Concerns Tagged With: CDC, Dr. Markoqitz, HPV genotyping, post-HPV vaccination monitoring, Sane Vax

Trackbacks

  1. SANE Vax to CDC: Request for post-HPV vaccination monitoring data | ONE MORE GIRL says:
    May 6, 2013 at 4:09 pm

    […] Read letter here: […]

    Reply

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Follow Us

SaneVax on FacebookSaneVax on TwitterSaneVax on LinkedInSaneVax on YoutubeSaneVax RSS Feed

Help Support SaneVax

Notice: We need your support. This massive research & presentation comes from a team of volunteers. We need your help to keep this critical information available.



SaneVax relies on support from participants like you. We are a 501 (c)(3) non-profit corporation, donations are tax deductible. Help keep this venue available and support the spirit – Thank you!

This Week’s Survivor

Finding Hope after a Gardasil Disaster

Categories

Links

  • Creating an HPV Industry
  • File a VAERS Report
  • Gardasil and Unexplained Deaths
  • HPV Industry Timeline
  • HPV Mechanisms of Action in Women
  • HPV Vaccine Fact Sheet
  • Petition: Rescind HPV Vaccine Approval
  • Presentation to the FDA
  • Supreme Court Arguments

HPV Vaccine VAERS Reports

Description 12/14/2019  TOTAL
Disabled 3,092
Deaths 523
Did Not Recover 13,072
Abnormal Smear 695
Cervical Cancer 186
Infertility 52
Life-threatening 1,001
Emergency Room 15,419
Hospitalized 6,448
Extended Hosp. Stay 304
Serious 9,497
Total Adverse Events 64,270

Access expanded report here.

Related

Subscribe2


 

Log In

Featured Video

Gardasil Vaccine, Injection of Death!: Dr. Sherri Tenpenny Reports

News

SaneVax News Blog!
News

Videos

Safety • Victims • Pharma
No Genetic Epidemic

Contact

Contact S.A.N.E.Vax
S.A.N.E.VAX log thumbnail

Copyright © 2023 SaneVax, Inc. · Site by TheWebElves.com a div. of KalaRhythms.org · Log in

 

Loading Comments...